[Diagnosis of skeletal tumors using 113mIn-indifor].
A new Soviet osteotropic agent 113mIn-indifor was used in clinical practice in 88 patients with primary (56), secondary (22), and systemic (10) skeletal diseases. The sensitivity of the method was 87.7%, its specificity--75%. The main indication for its use was a search for new or additional metastatic foci in malignant tumors of various sites. Investigations using 113mIn-indifor and 99m Tc-phosphates were conducted in 35 patients with different skeletal lesions. The authors obtained the results indicating the same informative value of both radiopharmaceuticals--90.3%. In view of some difficulties in supplies of generators of technetium, 113mIn-indifor can replace 99m Tc-phosphates in routine investigations of primary and especially metastatic skeletal lesions.
Mechev
D S
DS
Siniuta
B F
BF
D001859:Bone Neoplasms / Q000000981:diagnostic imaging* / Q000556:secondary; D001842:Bone and Bones / Q000000981:diagnostic imaging; D002986:Clinical Trials as Topic; D011756:Diphosphates; D004164:Diphosphonates; D005188:False Negative Reactions; D005189:False Positive Reactions; D006801:Humans; D007205:Indium Radioisotopes; D009943:Organophosphorus Compounds; D011877:Radionuclide Imaging; D013667:Technetium; D017556:Technetium Compounds; D016698:Technetium Tc 99m Pyrophosphate
D011756:Diphosphates; D004164:Diphosphonates; D007205:Indium Radioisotopes; D009943:Organophosphorus Compounds; D017556:Technetium Compounds; C049735:indifor; D016698:Technetium Tc 99m Pyrophosphate; D013667:Technetium; C029045:technetium Tc 99m diphosphonate
Diagnostika opukholeĭ skeleta s pomoshch'iu 113mIn-indifora.